{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:44:12Z","timestamp":1773715452273,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,22]]},"DOI":"10.7759\/cureus.67532","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T22:21:00Z","timestamp":1724365260000},"source":"Crossref","is-referenced-by-count":7,"title":["Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Brynne  E","family":"Tynes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coplen  D","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuri  H","family":"Vaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brennan","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Vu\u010denovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Potharaju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Lopez Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan D","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Seborrheic dermatitis","author":"Tucker D","year":"2024","unstructured":"Tucker D, Masood S. Seborrheic dermatitis. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024. 19:"},{"key":"ref2","unstructured":"Diagnosing Disorders of Facial Erythema. (2023). Accessed. June 19, 2024: https:\/\/www.clinicalkey.com\/#!\/content\/playContent\/1-s2.0-S0733863523000141?scrollTo=%23hl0000731."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000529854","article-title":"Scalp seborrheic dermatitis: what we know so far","volume":"9","author":"Leroy AK","year":"2023","unstructured":"Leroy AK, Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. Scalp seborrheic dermatitis: what we know so far. Skin Appendage Disord. 2023, 9:160-4. 10.1159\/000529854","journal-title":"Skin Appendage Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1984.tb03398.x","article-title":"Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use","volume":"4","author":"Van Tyle JH","year":"1984","unstructured":"Van Tyle JH. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy. 1984, 4:343-73. 10.1002\/j.1875-9114.1984.tb03398.x","journal-title":"Pharmacotherapy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14505","article-title":"Ketoconazole beyond antifungal activity: bioinformatics-based hypothesis on lipid metabolism in dandruff and seborrheic dermatitis","volume":"31","author":"Goularte-Silva V","year":"2022","unstructured":"Goularte-Silva V, Paulino LC. Ketoconazole beyond antifungal activity: bioinformatics-based hypothesis on lipid metabolism in dandruff and seborrheic dermatitis. Exp Dermatol. 2022, 31:821-2. 10.1111\/exd.14505","journal-title":"Exp Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1573309","article-title":"Topical ketoconazole: a systematic review of current dermatological applications and future developments","volume":"30","author":"Choi FD","year":"2019","unstructured":"Choi FD, Juhasz ML, Atanaskova Mesinkovska N. Topical ketoconazole: a systematic review of current dermatological applications and future developments. J Dermatolog Treat. 2019, 30:760-71. 10.1080\/09546634.2019.1573309","journal-title":"J Dermatolog Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000512189","article-title":"A review of the current evidence connecting seborrheic dermatitis and Parkinson\u2019s disease and the potential role of oral cannabinoids","volume":"237","author":"Rietcheck HR","year":"2021","unstructured":"Rietcheck HR, Maghfour J, Rundle CW, et al.. A review of the current evidence connecting seborrheic dermatitis and Parkinson\u2019s disease and the potential role of oral cannabinoids. Dermatology. 2021, 237:872-7. 10.1159\/000512189","journal-title":"Dermatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S323744","article-title":"Prevalence and associated diseases of seborrheic skin in adults","volume":"13","author":"Kirsten N","year":"2021","unstructured":"Kirsten N, Mohr N, Alhumam A, Augustin M. Prevalence and associated diseases of seborrheic skin in adults. Clin Epidemiol. 2021, 13:845-51. 10.2147\/CLEP.S323744","journal-title":"Clin Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02900-w","article-title":"Epidemiology of seborrheic dermatitis among adults in the United States: a cross-sectional analysis","volume":"316","author":"Haq Z","year":"2024","unstructured":"Haq Z, Abdi P, Wan V, et al.. Epidemiology of seborrheic dermatitis among adults in the United States: a cross-sectional analysis. Arch Dermatol Res. 2024, 316:394. 10.1007\/s00403-024-02900-w","journal-title":"Arch Dermatol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52139","article-title":"Atypical mycobacterial infection mimicking psoriasis in an elderly patient: diagnostic challenges and management","volume":"16","author":"Arshad M","year":"2024","unstructured":"Arshad M, Kumar A, Shafique Ur Rehman M, Tito Rodriguez PR, Varrassi G. Atypical mycobacterial infection mimicking psoriasis in an elderly patient: diagnostic challenges and management. Cureus. 2024, 16:e52139. 10.7759\/cureus.52139","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14091","article-title":"An update on the microbiology, immunology and genetics of seborrheic dermatitis","volume":"29","author":"Adalsteinsson JA","year":"2020","unstructured":"Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol. 2020, 29:481-9. 10.1111\/exd.14091","journal-title":"Exp Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00758","article-title":"Malassezia and Parkinson's disease","volume":"10","author":"Laurence M","year":"2019","unstructured":"Laurence M, Benito-Le\u00f3n J, Calon F. Malassezia and Parkinson's disease. Front Neurol. 2019, 10:758. 10.3389\/fneur.2019.00758","journal-title":"Front Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15804","article-title":"Establishment of clinical evaluation criteria for scalp seborrheic dermatitis","volume":"22","author":"Zhang F","year":"2023","unstructured":"Zhang F, Li Y, Ren W, Li S. Establishment of clinical evaluation criteria for scalp seborrheic dermatitis. J Cosmet Dermatol. 2023, 22:3042-6. 10.1111\/jocd.15804","journal-title":"J Cosmet Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S284671","article-title":"An overview of the diagnosis and management of seborrheic dermatitis","volume":"15","author":"Dall'Oglio F","year":"2022","unstructured":"Dall'Oglio F, Nasca MR, Gerbino C, Micali G. An overview of the diagnosis and management of seborrheic dermatitis. Clin Cosmet Investig Dermatol. 2022, 15:1537-48. 10.2147\/CCID.S284671","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref15","article-title":"Dermatoscopy in inflammatory and infectious skin disorders","volume":"150","author":"Lacarrubba F","year":"2015","unstructured":"Lacarrubba F, Verz\u00ec AE, Dinotta F, Scavo S, Micali G. Dermatoscopy in inflammatory and infectious skin disorders. G Ital Dermatol Venereol. 2015, 150:521-31.","journal-title":"G Ital Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.13188\/2373-1044.1000019","article-title":"Seborrheic dermatitis and dandruff: a comprehensive review","volume":"3","author":"Borda LJ","year":"2015","unstructured":"Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015, 3:19. 10.13188\/2373-1044.1000019","journal-title":"J Clin Investig Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03828.x","article-title":"Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis","volume":"143","author":"Pirkhammer D","year":"2000","unstructured":"Pirkhammer D, Seeber A, H\u00f6nigsmann H, Tanew A. Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol. 2000, 143:964-8. 10.1046\/j.1365-2133.2000.03828.x","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/11538110-000000000-00000","article-title":"Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent","volume":"70","author":"Subissi A","year":"2010","unstructured":"Subissi A, Monti D, Togni G, Mailland F. Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. Drugs. 2010, 70:2133-52. 10.2165\/11538110-000000000-00000","journal-title":"Drugs"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1986.tb04878.x","article-title":"Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone","volume":"114","author":"Faergemann J","year":"1986","unstructured":"Faergemann J. Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone. Br J Dermatol. 1986, 114:695-700. 10.1111\/j.1365-2133.1986.tb04878.x","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06208.x","article-title":"Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial","volume":"151","author":"Rigopoulos D","year":"2004","unstructured":"Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004, 151:1071-5. 10.1111\/j.1365-2133.2004.06208.x","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10269.x","article-title":"Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0\u00b705% combined with ketoconazole shampoo 2%: a randomized, controlled study","volume":"165","author":"Ortonne JP","year":"2011","unstructured":"Ortonne JP, Nikkels AF, Reich K, et al.. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0\u00b705% combined with ketoconazole shampoo 2%: a randomized, controlled study. Br J Dermatol. 2011, 165:171-6. 10.1111\/j.1365-2133.2011.10269.x","journal-title":"Br J Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.1997.tb01115.x","article-title":"Susceptibility of Malassezia furfur subgroups to terbinafine","volume":"137","author":"Leeming JP","year":"1997","unstructured":"Leeming JP, Sansom JE, Burton JL. Susceptibility of Malassezia furfur subgroups to terbinafine. Br J Dermatol. 1997, 137:764-7.","journal-title":"Br J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.87137","article-title":"Oral itraconazole for the treatment of severe seborrhoeic dermatitis","volume":"56","author":"Das J","year":"2011","unstructured":"Das J, Majumdar M, Chakraborty U, Majumdar V, Mazumdar G, Nath J. Oral itraconazole for the treatment of severe seborrhoeic dermatitis. Indian J Dermatol. 2011, 56:515-6. 10.4103\/0019-5154.87137","journal-title":"Indian J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/039463200501800418","article-title":"Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study","volume":"18","author":"Vena GA","year":"2005","unstructured":"Vena GA, Micali G, Santoianni P, Cassano N, Peruzzi E. Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol. 2005, 18:745-53. 10.1177\/039463200501800418","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2005.01090.x","article-title":"Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial","volume":"19","author":"Kose O","year":"2005","unstructured":"Kose O, Erbil H, Gur AR. Oral itraconazole for the treatment of seborrhoeic dermatitis: an open, noncomparative trial. J Eur Acad Dermatol Venereol. 2005, 19:172-5. 10.1111\/j.1468-3083.2005.01090.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref26","article-title":"Ketoconazole","author":"Sinawe H","year":"2024","unstructured":"Sinawe H, Casadesus D. Ketoconazole. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024. 17:"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198814010-00002","article-title":"Clinical pharmacokinetics of ketoconazole","volume":"14","author":"Daneshmend TK","year":"1988","unstructured":"Daneshmend TK, Warnock DW. Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet. 1988, 14:13-34. 10.2165\/00003088-198814010-00002","journal-title":"Clin Pharmacokinet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02168.x","article-title":"Skin blister fluid levels of ketoconazole during repetitive administration in healthy man","volume":"32","author":"Korting HC","year":"1989","unstructured":"Korting HC, Lukacs A, Sch\u00e4fer-Korting M, Heykants J, Behrendt H. Skin blister fluid levels of ketoconazole during repetitive administration in healthy man. Mycoses. 1989, 32:39-45. 10.1111\/j.1439-0507.1989.tb02168.x","journal-title":"Mycoses"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.02.022","article-title":"Development, optimization, and antifungal assessment of ocular gel loaded with ketoconazole cubic liquid crystalline nanoparticles","volume":"110","author":"Elfaky MA","year":"2021","unstructured":"Elfaky MA, Sirwi A, Tolba HH, et al.. Development, optimization, and antifungal assessment of ocular gel loaded with ketoconazole cubic liquid crystalline nanoparticles. J Pharm Sci. 2021, 110:2210-20. 10.1016\/j.xphs.2021.02.022","journal-title":"J Pharm Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502900102","article-title":"Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis","volume":"29","author":"Force RW","year":"1995","unstructured":"Force RW, Nahata MC. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother. 1995, 29:10-5. 10.1177\/106002809502900102","journal-title":"Ann Pharmacother"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)51922-9","article-title":"Ketoconazole therapy for fungal urinary tract infections","volume":"129","author":"Graybill JR","year":"1983","unstructured":"Graybill JR, Galgiani JN, Jorgensen JH, Strandberg DA. Ketoconazole therapy for fungal urinary tract infections. J Urol. 1983, 129:68-70. 10.1016\/S0022-5347(17)51922-9","journal-title":"J Urol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.1.151","article-title":"Disposition of ketoconazole, an oral antifungal, in humans","volume":"21","author":"Brass C","year":"1982","unstructured":"Brass C, Galgiani JN, Blaschke TF, Defelice R, O'Reilly RA, Stevens DA. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982, 21:151-8. 10.1128\/AAC.21.1.151","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1128\/aac.38.1.90","article-title":"In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum","volume":"38","author":"Pershing LK","year":"1994","unstructured":"Pershing LK, Corlett J, Jorgensen C. In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum. Antimicrob Agents Chemother. 1994, 38:90-5. 10.1128\/aac.38.1.90","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","article-title":"Comparison of topical and oral ketoconazole in the treatment of intractable seborrheic dermatitis","volume":"3","author":"Emad M","year":"2000","unstructured":"Emad M, Hosseini SMN. Comparison of topical and oral ketoconazole in the treatment of intractable seborrheic dermatitis. Iran J Dermatol. 2000, 3:18-22.","journal-title":"Iran J Dermatol"},{"key":"ref35","article-title":"Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor","volume":"287","author":"Nagpal VB","year":"2003","unstructured":"Nagpal VB, Jain VK, Aggarwal K. Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor. Indian J Dermatol Venereol Leprol. 2003, 287:27.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref36","unstructured":"Oral ketoconazole. do not prescribe or use for fungal infections\u2014risk of liver injury outweighs benefits. (2014). Accessed: June 27, 2024: https:\/\/www.gov.uk\/drug-safety-update\/oral-ketoconazole-do-not-prescribe-or-use-for-fungal-infections-risk-of-liver-i...."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08680.x","article-title":"Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial","volume":"132","author":"Peter RU","year":"1995","unstructured":"Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol. 1995, 132:441-5. 10.1111\/j.1365-2133.1995.tb08680.x","journal-title":"Br J Dermatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1159\/000051628","article-title":"Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments","volume":"202","author":"Pi\u00e9rard-Franchimont C","year":"2001","unstructured":"Pi\u00e9rard-Franchimont C, Pi\u00e9rard GE, Arrese JE, De Doncker P. Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments. Dermatology. 2001, 202:171-6. 10.1159\/000051628","journal-title":"Dermatology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2340\/0001555570171172","article-title":"Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. A double-blind study","volume":"70","author":"Faergemann J","year":"1990","unstructured":"Faergemann J. Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. A double-blind study. Acta Derm Venereol. 1990, 70:171-2. 10.2340\/0001555570171172","journal-title":"Acta Derm Venereol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1159\/000066452","article-title":"A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis","volume":"15","author":"Pi\u00e9rard-Franchimont C","year":"2002","unstructured":"Pi\u00e9rard-Franchimont C, Goffin V, Decroix J, Pi\u00e9rard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002, 15:434-41. 10.1159\/000066452","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1467-2494.1999.201638.x","article-title":"Squamometry: a tool to move from exaggerated to more and more realistic application conditions for comparing the skin compatibility of surfactant-based products","volume":"21","author":"Paye M","year":"1999","unstructured":"Paye M, Cartiaux Y. Squamometry: a tool to move from exaggerated to more and more realistic application conditions for comparing the skin compatibility of surfactant-based products. Int J Cosmet Sci. 1999, 21:59-68. 10.1046\/j.1467-2494.1999.201638.x","journal-title":"Int J Cosmet Sci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1987.tb05815.x","article-title":"Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole","volume":"116","author":"Green CA","year":"1987","unstructured":"Green CA, Farr PM, Shuster S. Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole. Br J Dermatol. 1987, 116:217-21. 10.1111\/j.1365-2133.1987.tb05815.x","journal-title":"Br J Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1159\/000439354","article-title":"Noncorticosteroid combination shampoo versus 1% ketoconazole shampoo for the management of mild-to-moderate seborrheic dermatitis of the scalp: results from a randomized, investigator-single-blind trial using clinical and trichoscopic evaluation","volume":"1","author":"Dall'Oglio F","year":"2016","unstructured":"Dall'Oglio F, Lacarrubba F, Verz\u00ec AE, Micali G. Noncorticosteroid combination shampoo versus 1% ketoconazole shampoo for the management of mild-to-moderate seborrheic dermatitis of the scalp: results from a randomized, investigator-single-blind trial using clinical and trichoscopic evaluation. Skin Appendage Disord. 2016, 1:126-30. 10.1159\/000439354","journal-title":"Skin Appendage Disord"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.782092","article-title":"Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp","volume":"25","author":"Buechner SA","year":"2014","unstructured":"Buechner SA. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. J Dermatolog Treat. 2014, 25:226-31. 10.3109\/09546634.2013.782092","journal-title":"J Dermatolog Treat"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2340\/0001555577132134","article-title":"Effect of ketoconazole 2% shampoo on scalp sebum level in patients with seborrhoeic dermatitis","volume":"77","author":"Dobrev H","year":"1997","unstructured":"Dobrev H, Zissova L. Effect of ketoconazole 2% shampoo on scalp sebum level in patients with seborrhoeic dermatitis. Acta Derm Venereol. 1997, 77:132-4. 10.2340\/0001555577132134","journal-title":"Acta Derm Venereol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1987.tb05814.x","article-title":"Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole","volume":"116","author":"Carr MM","year":"1987","unstructured":"Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br J Dermatol. 1987, 116:213-6. 10.1111\/j.1365-2133.1987.tb05814.x","journal-title":"Br J Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1080\/16537150601092944","article-title":"Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis","volume":"18","author":"Ratnavel RC","year":"2007","unstructured":"Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat. 2007, 18:88-96. 10.1080\/16537150601092944","journal-title":"J Dermatolog Treat"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/095466302317584395","article-title":"A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff\/seborrhoeic dermatitis","volume":"13","author":"Squire RA","year":"2002","unstructured":"Squire RA, Goode K. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff\/seborrhoeic dermatitis. J Dermatolog Treat. 2002, 13:51-60. 10.1080\/095466302317584395","journal-title":"J Dermatolog Treat"},{"key":"ref49","article-title":"The Myrtus communis L. solution versus ketoconazole shampoo in treatment of dandruff: a double blinded randomized clinical trial","volume":"68","author":"Chaijan MR","year":"2018","unstructured":"Chaijan MR, Handjani F, Zarshenas M, Rahimabadi MS, Tavakkoli A. The Myrtus communis L. solution versus ketoconazole shampoo in treatment of dandruff: a double blinded randomized clinical trial. J Pak Med Assoc. 2018, 68:715-20.","journal-title":"J Pak Med Assoc"},{"key":"ref50","unstructured":"Ketoconazole cream. (2024). Accessed. June 12, 2024: https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=39b85d6a-9133-42e6-b7f8-58f045e9b9f0&type=display."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/284759-ketoconazole-shampoo-for-seborrheic-dermatitis-of-the-scalp-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T22:21:07Z","timestamp":1724365267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/284759-ketoconazole-shampoo-for-seborrheic-dermatitis-of-the-scalp-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.67532","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}